Gujarat Themis Biosyn Ltd – Bulk Drugs growth momentum

Thanks Tarun for your insights. Couple of quick questions:

1. Is the Rifampicin market functioning as a cyclical commodity? In the sense, has there been a dramatic rise in the price of these API intermediaries in open market…any chances of mean reversion when chinese suppliers come back etc.?

2. Is fermentation the only way to produce these APIs or is custom synthesis chemically an option as well?

3. Any reason for clients to prefer GTBL? ( Cost, FDA approval etc.) over the longer period ?

Thanks for the time.